-+ 0.00%
-+ 0.00%
-+ 0.00%

Novartis suspended trading after the DEL-DESIRAN drug trial was thwarted, and recently fell 8.8%.

Zhitongcaijing·09/08/2026 07:17:02
Listen to the news
Novartis suspended trading after the DEL-DESIRAN drug trial was thwarted, and recently fell 8.8%.